These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 1331020

  • 1. Safety and efficacy of temafloxacin versus ciprofloxacin in lower respiratory tract infections: a randomized, double-blind trial.
    Lindsay G, Scorer HJ, Carnegie CM.
    J Antimicrob Chemother; 1992 Jul; 30(1):89-100. PubMed ID: 1331020
    [Abstract] [Full Text] [Related]

  • 2. Efficacy of temafloxacin versus ciprofloxacin or amoxicillin for lower respiratory tract infections in smokers and the elderly.
    Davey PG.
    Am J Med; 1991 Dec 30; 91(6A):101S-105S. PubMed ID: 1662877
    [Abstract] [Full Text] [Related]

  • 3. Temafloxacin compared with ciprofloxacin in mild to moderate lower respiratory tract infections in ambulatory patients. A multicenter, double-blind, randomized study.
    Chodosh S.
    Chest; 1991 Dec 30; 100(6):1497-502. PubMed ID: 1659975
    [Abstract] [Full Text] [Related]

  • 4. A double-blind study of once-daily temafloxacin in the treatment of bacterial lower respiratory tract infections.
    Kosmidis J.
    J Antimicrob Chemother; 1991 Dec 30; 28 Suppl C():73-9. PubMed ID: 1664832
    [Abstract] [Full Text] [Related]

  • 5. Systemic antimicrobial therapy in skin and skin structure infections: comparison of temafloxacin and ciprofloxacin.
    Parish LC, Jungkind DL.
    Am J Med; 1991 Dec 30; 91(6A):115S-119S. PubMed ID: 1662880
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Comparison of three-day temafloxacin with seven-day ciprofloxacin treatment of urinary tract infections in women.
    Stein GE, Philip E.
    J Fam Pract; 1992 Feb 30; 34(2):180-4. PubMed ID: 1310715
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Activity of temafloxacin against respiratory pathogens.
    Swanson RN, Hardy DJ, Chu DT, Shipkowitz NL, Clement JJ.
    Antimicrob Agents Chemother; 1991 Mar 30; 35(3):423-9. PubMed ID: 2039192
    [Abstract] [Full Text] [Related]

  • 11. A comparison of the safety and efficacy of lomefloxacin and ciprofloxacin in the treatment of complicated or recurrent urinary tract infections.
    Cox CE.
    Am J Med; 1992 Apr 06; 92(4A):82S-86S. PubMed ID: 1316077
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Activity of temafloxacin and other fluoroquinolones against typical and atypical community-acquired respiratory tract pathogens.
    Hardy DJ.
    Am J Med; 1991 Dec 30; 91(6A):12S-14S. PubMed ID: 1662881
    [Abstract] [Full Text] [Related]

  • 14. Efficacy and safety of a 10-day course of 400 or 600 milligrams of grepafloxacin once daily for treatment of acute bacterial exacerbations of chronic bronchitis: comparison with a 10-day course of 500 milligrams of ciprofloxacin twice daily.
    Chodosh S, Lakshminarayan S, Swarz H, Breisch S.
    Antimicrob Agents Chemother; 1998 Jan 30; 42(1):114-20. PubMed ID: 9449270
    [Abstract] [Full Text] [Related]

  • 15. Use of quinolones for the treatment of acute exacerbations of chronic bronchitis.
    Chodosh S.
    Am J Med; 1991 Dec 30; 91(6A):93S-100S. PubMed ID: 1662900
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Lomefloxacin and temafloxacin: two new fluoroquinolone antimicrobials.
    Symonds WT, Nix DE.
    Clin Pharm; 1992 Sep 30; 11(9):753-66. PubMed ID: 1325892
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.